ProCAncer-I in the IEEE-MeMeA Conference in Taormina

Published on: June 17, 2022
Categories: News
We are looking forward to participating it the upcoming IEEE-MeMeA Conference in Taormina! The 17th edition of IEEE International Symposium on Medical Measurements and Applications will take place in Giardini Naxos, Taormina in the metropolitan area of Messina, Italy, from June 22nd to 24th.
Dr. Valentina Giannini (FPO) and Dr. João Santinha (FCHAMP) will chair a special session (no.14) entitled “AI-POWERED MEDICAL IMAGE ANALYSIS: RADIOMICS FOR PERSONALIZED PATIENTS’ MANAGEMENT” (https://memea2022.ieee-ims.org/special-sessons/). The session is designed to cover all aspects related to the development of AI-based imaging biomarkers and techniques, for personalizing management of patients and including the challenges which need to be addressed before translation of AI to clinical use, as explainability of the models, reproducibility of quantitative imaging features, sensitivity of the results to image acquisition and reconstruction parameters. In this special session, Dr. Giovanni Maimone (FPO) will present a study entitled “Comparison of Machine and Deep Learning models for automatic segmentation of prostate cancers on multiparametric MR” acknowledging the Pro-Cancer-I project.
For more information about the Conference: https://memea2022.ieee-ims.org/

Highlights

European Cancer Imaging Initiative launch event

European Cancer Imaging Initiative launch event

The Commission is organising a hybrid event on 23 January 2023 in Brussels to mark the launch of the Cancer Imaging Initiative, one of the Flagship Initiatives of the Europe’s Beating Cancer Plan. This 2.5-hour event will present the policy background and the Cancer...

ProCAncer-I at the RSNA 2022 in Chicago

ProCAncer-I at the RSNA 2022 in Chicago

Our Scientific Manager, Dr Nickolas Papanikolaou was at the 108th Scientific Assembly and Annual meeting (Chicago 27-30/11/2022). The panel discussion included Dr Mona Flores, Global Head of Medical AI at NVIDIA, and Dr Nikos Papanikolaou, Computational Clinical...

Stay in touch!